These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6533887)

  • 1. A new cartridge for phosphate removal in uremic patients.
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F
    Trans Am Soc Artif Intern Organs; 1984; 30():199-202. PubMed ID: 6533887
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum middle molecule levels in uremia during long term intermittent hemoperfusions with the acac (coated charcoal) microcapsule artificial kidney.
    Chang TM; Migchelsen M; Coffey JF; Stark A
    Trans Am Soc Artif Intern Organs; 1974; 20A():364-71. PubMed ID: 4217485
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of the blood chemistry parameters in the oral cavity treatment of chronic uremic patients].
    Tarello F; Giugiaro E; Vergnano G
    Minerva Stomatol; 1985; 34(4):657-64. PubMed ID: 3900678
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will nephrologists use a wearable artificial kidney?
    Friedman EA
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1401-2. PubMed ID: 19661217
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal changes in uremia.
    Bonomini V; Orsoni G; Stefoni S; Vangelista A
    Clin Nephrol; 1979 Jun; 11(6):275-80. PubMed ID: 477043
    [No Abstract]   [Full Text] [Related]  

  • 9. The so-called "onion-like shape thromboelastogram" in dialyzed uraemic patients.
    Suchecki T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):513-6. PubMed ID: 4424222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uremic pericarditis (its clinical aspects and treatment)].
    Ermolenko VM; Balkarov IM; Chegaev VA; Lifshits NL
    Sov Med; 1974; 0(4):96-100. PubMed ID: 4838587
    [No Abstract]   [Full Text] [Related]  

  • 14. The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney.
    Chang TM; Malave N
    Trans Am Soc Artif Intern Organs; 1970; 16():141-8. PubMed ID: 5454159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical therapeutic experiences in chronic kidney failure with metabolic acidosis and phosphate retention].
    Kotzaurek R; Pall H; Schmidt P; Widhalm F; Zazgornik J
    Wien Med Wochenschr; 1971 Mar; 121(13):246-9. PubMed ID: 5560229
    [No Abstract]   [Full Text] [Related]  

  • 16. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy].
    Desjacques P
    Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101
    [No Abstract]   [Full Text] [Related]  

  • 17. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate removal during dialysis--does the membrane matter?
    Ritz E
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can dialysis be conducted too often?].
    Alscher D
    Dtsch Med Wochenschr; 2003 Feb; 128(9):457. PubMed ID: 12612860
    [No Abstract]   [Full Text] [Related]  

  • 20. Removal of phosphate either by bicarbonate dialysis or biofiltration in uremics.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Morachiello P
    Kidney Int Suppl; 1988 Mar; 24():S180-3. PubMed ID: 3163046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.